Back to search
FDAFDA · Food and drugs·Recall number D-0320-2024

HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-447-01; NDC Unit Dose: 68084-447-11

Published February 14, 2024 · Recall initiated: February 1, 2024

Summary

FDA records drug Class III recall D-0320-2024, published February 14, 2024 and initiated February 1, 2024. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 2,850 cartons; Lot: Lot #: 1012275, Exp 02/28/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lot #: 1012275, Exp 02/28/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-447-01; NDC Unit Dose: 68084-447-11 recalled?

Yes. FDA published recall D-0320-2024 on February 14, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter